Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/04/2003US20030224423 Method of testing for allergic diseases
12/04/2003US20030224421 Fluorescent conjugates for use in immunoassays and for DNA analysis
12/04/2003US20030224420 Using differential labeling of progenitor tissue separate cell of different cell lineage and to detect carcinogenesis, cell proliferative, autoimmune and diabetic; nuclear magnetic resonance; antiproliferative agents; mass spectrometry
12/04/2003US20030224419 Data analysis and display system for ligation-based DNA sequencing
12/04/2003US20030224417 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
12/04/2003US20030224416 Diagnosing psychological disorders via detection of transcriptional variants in gene coding membrane proteins associated electrical potential; drug screening
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224406 MBCATs as modifiers of the beta-catenin pathway and methods of use
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224401 Proteins for helicobacter diagnosis
12/04/2003US20030224399 Methods for determining the prognosis for patients with a prostate neoplastic condition
12/04/2003US20030224398 Purification of the leading front of migratory cells
12/04/2003US20030224394 Computer systems and methods for identifying genes and determining pathways associated with traits
12/04/2003US20030224391 Rigidized trimethine cyanine dyes
12/04/2003US20030224390 Screening combinatorial peptide libraries for identifing amino acid sequences which bind and activate cellular processes; drug screening
12/04/2003US20030224388 RIP2: a mediator of signaling in the innate and adaptive immune systems
12/04/2003US20030224387 Association of molecules with electrodes of an array of electrodes
12/04/2003US20030224386 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/04/2003US20030224382 Measuring concentration of two or more nucleic acid molecules in target cell for use in diagnosing and treating cancer, autoimmune, infectious, aging, developmental, proliferative and neurological disorders
12/04/2003US20030224377 Novel LNA compositions and uses thereof
12/04/2003US20030224374 Classifying/diagnosing/prognosing tumorous condition via presence of estrogen receptor
12/04/2003US20030224373 Using glucose-6-phosphate dehydrogenous conjugagte for Detecting one or more non-serologically cross-reactive analyte types in a sample; drug screening; genetic analysis; identifying biological warfare agents
12/04/2003US20030224370 Method and apparatus for recognizing molecular compounds
12/04/2003US20030224369 Reverse screening and target identification with minicells
12/04/2003US20030224365 Single nucleotide polymorphisms diagnostic for schizophrenia
12/04/2003US20030224362 Diagnosing alcoholism using presence of mutation in neuropeptide y gene; drug abuse; restriction fragment length polymorphisms; immunoassay
12/04/2003US20030224361 Method of making random array of microspheres using enzyme digestion
12/04/2003US20030224360 Interventions to mimic the effects of calorie restriction
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224355 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (alpha), HNF-1beta and HNF-4alpha
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224349 Identifying antiinflammatory compounds that minimize and/or stimulate osteoblast differentiation; diagnosing and treating bone disorder; drug screening; side effect reduction
12/04/2003US20030224348 Methods of screening for SCAP antagonists
12/04/2003US20030224347 Pharmaceutical compositions
12/04/2003US20030224346 Determining molecular weight distribution of anionic polysaccharides such as chondroitin sulfate, keratan sulfate, dermatan sulfate, heparin sulfate and/or heparan sulfate
12/04/2003US20030224345 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
12/04/2003US20030224344 Method and system for clustering data
12/04/2003US20030224343 Kappa-PVIIA-related conotoxins as organ protectants
12/04/2003US20030224040 Genomic screen for epigenetically silenced genes associated with cancer
12/04/2003US20030224016 Transport peptides such as C-terminal Erns peptide and analogues thereof
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030223998 Use of gamma delta + T cells to identify and respond to a specific antigen expressed by acute lymphoblstic leukemia (ALL)
12/04/2003US20030223996 Analyzing the level of B lymphocte stimulator (BLyS) expression in a sample of an individual using antibodies, comparing the level of BLyS assayed in biological sample with a standard level of BLyS expresion in normal sample
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030223980 Uses of thioredoxin
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223959 Diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that Chlamydia is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sustain neurological
12/04/2003US20030223911 Identically shaped spots can be formed sequentially and stably by a spotting pin comprising a bar-like plunger 20. Four projections each formed in the shape of a top portion of a quadrangular pyramid are formed on the head of the plunger
12/04/2003US20030223065 Method and a device for determining the radiation-damage resistance of an optical material
12/04/2003US20030222656 On-line oil condition sensor system for rotating and reciprocating machinery
12/04/2003US20030222232 Sensor
12/04/2003US20030221976 A radiator in a motor vehicle the device having a first air-guidance passage and a second air-guidance passage for receiving air upstream and downstream of the ozone conversion element, the air-guidance passages being connected via a
12/04/2003US20030221495 Powder sampling method and apparatus
12/04/2003US20030221477 Packaging an analyte- containing fluid calibrant. The cartridge is formed from a container having an opening sealed by a sealing member. A septum divides the container into a calibrant compartment and an outer compartment. A probe is
12/04/2003DE20312150U1 System for determining beta-glucan in beverages, comprises buffered solution of dye that forms colored complex with beta-glucan, provides rapid results and uses standard instruments
12/04/2003CA2771788A1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003CA2704273A1 Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
12/04/2003CA2494134A1 Treatment for diabetes
12/04/2003CA2492380A1 An exposure device
12/04/2003CA2487454A1 Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
12/04/2003CA2487322A1 Animal genotyping method
12/04/2003CA2487303A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2487093A1 Microarrays and method for running hybridization reaction for multiple samples on a single microarray
12/04/2003CA2487006A1 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486716A1 Compositions and their uses for alleviating pain
12/04/2003CA2486685A1 Method and apparatus for measuring white blood cell count
12/04/2003CA2486619A1 Methods and materials for treating inflammatory conditions
12/04/2003CA2486615A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2486431A1 Computer systems and methods for subdividing a complex disease into component diseases
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2486218A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2485988A1 Methods of modulating tubulin deacetylase activity
12/04/2003CA2485825A1 Method for identification of a ligand whereby receptor residence time is measured
12/04/2003CA2485184A1 Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2484010A1 Pna probes, probe sets, methods and kits pertaining to the determination of listeria
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003CA2482881A1 Diagnosis of hepatocellular carcinoma
12/04/2003CA2481665A1 Automatic point source biological agent detection system
12/04/2003CA2480742A1 Tropane compounds
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/04/2003CA2452904A1 Method for evaluating suittability of barley ingredient as ingredient for malt manufacture with a dyeing method
12/03/2003EP1367397A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 1 (SSTR1)
12/03/2003EP1367396A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (CCR10)
12/03/2003EP1367395A1 Diagnosis of neoplasms with the help of anti-gangliosid-antibodies
12/03/2003EP1367394A1 Method for detecting and ascertaining the presence of active ingredients in herbs
12/03/2003EP1367393A1 Methods for using the CD 163 pathway for modulating an immune response
12/03/2003EP1367392A1 Method and device for measuring blood gas parameters
12/03/2003EP1367391A1 Method and apparatus for determining oxygen in a metal
12/03/2003EP1367387A2 Solid electrolyte sensor for detecting a sulfurous component in a gas stream
12/03/2003EP1367384A1 Apparatus for displaying an image of all the chromosomes of a human cell